Gilbert N. Lam

981 total citations
43 papers, 792 citations indexed

About

Gilbert N. Lam is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Gilbert N. Lam has authored 43 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Pharmacology and 9 papers in Pharmacology. Recurrent topics in Gilbert N. Lam's work include Analytical Methods in Pharmaceuticals (6 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Gilbert N. Lam is often cited by papers focused on Analytical Methods in Pharmaceuticals (6 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Gilbert N. Lam collaborates with scholars based in United States, Canada and Netherlands. Gilbert N. Lam's co-authors include Win L. Chiou, Beverly C. Cordova, Ronald M. Klabe, Susan Erickson‐Viitanen, S.J. Pratten, K.P. Galvin, Mei‐Ling Chen, Alvin Wong, Pancras C. Wong and W. David Henner and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Gilbert N. Lam

41 papers receiving 756 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gilbert N. Lam United States 16 196 156 97 96 94 43 792
Stephen A. Bai United States 19 78 0.4× 157 1.0× 145 1.5× 126 1.3× 83 0.9× 34 847
Jörg Pohl Germany 12 86 0.4× 168 1.1× 57 0.6× 190 2.0× 63 0.7× 15 687
Poe‐Hirr Hsyu United States 16 46 0.2× 222 1.4× 77 0.8× 230 2.4× 151 1.6× 32 892
Hyung‐Doo Park South Korea 19 71 0.4× 487 3.1× 57 0.6× 91 0.9× 32 0.3× 165 1.5k
M. Thévenin France 11 74 0.4× 105 0.7× 57 0.6× 29 0.3× 52 0.6× 38 611
Peter R. Gwilt United States 17 26 0.1× 229 1.5× 93 1.0× 207 2.2× 119 1.3× 44 963
Tawfeeg A. Najjar Saudi Arabia 14 32 0.2× 144 0.9× 88 0.9× 146 1.5× 55 0.6× 26 726
Klaus Kutz Switzerland 21 63 0.3× 297 1.9× 220 2.3× 304 3.2× 141 1.5× 59 1.8k
E Albengres France 19 54 0.3× 353 2.3× 252 2.6× 203 2.1× 113 1.2× 68 986
Pankaj Wadhwa India 19 166 0.8× 347 2.2× 99 1.0× 89 0.9× 33 0.4× 98 1.3k

Countries citing papers authored by Gilbert N. Lam

Since Specialization
Citations

This map shows the geographic impact of Gilbert N. Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilbert N. Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilbert N. Lam more than expected).

Fields of papers citing papers by Gilbert N. Lam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilbert N. Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilbert N. Lam. The network helps show where Gilbert N. Lam may publish in the future.

Co-authorship network of co-authors of Gilbert N. Lam

This figure shows the co-authorship network connecting the top 25 collaborators of Gilbert N. Lam. A scholar is included among the top collaborators of Gilbert N. Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilbert N. Lam. Gilbert N. Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Honert, Eric C., et al.. (2022). A foot and footwear mechanical power theoretical framework: Towards understanding energy storage and return in running footwear. Journal of Biomechanics. 141. 111217–111217. 12 indexed citations
2.
Bonate, Peter L., Casey Cunningham, Paul S. Gaynon, et al.. (2010). Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer. Cancer Chemotherapy and Pharmacology. 67(4). 875–890. 24 indexed citations
3.
Beer, Tomasz M., Milind Javle, Christopher W. Ryan, et al.. (2006). Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancer. Cancer Chemotherapy and Pharmacology. 59(5). 581–587. 41 indexed citations
4.
Bonate, Peter L., Adam Craig, Paul S. Gaynon, et al.. (2004). Population Pharmacokinetics of Clofarabine, a Second‐Generation Nucleoside Analog, in Pediatric Patients With Acute Leukemia. The Journal of Clinical Pharmacology. 44(11). 1309–1322. 35 indexed citations
5.
Lam, Gilbert N., et al.. (2001). A high-performance liquid chromatography–tandem mass spectrometric method for the determination of pharmacokinetics of ganaxolone in rat, monkey, dog and human plasma. Journal of Chromatography B Biomedical Sciences and Applications. 751(1). 49–59. 17 indexed citations
6.
Lam, Gilbert N., et al.. (2000). Development of a high-performance liquid chromatographic–tandem mass spectrometric method for the determination of pharmacokinetics of Co 102862 in mouse, rat, monkey and dog plasma. Journal of Chromatography B Biomedical Sciences and Applications. 749(1). 1–15. 4 indexed citations
7.
Lam, Gilbert N., et al.. (2000). In Vivo Metabolism and Mass Balance of 4-[4-Fluorophenoxy]benzaldehyde Semicarbazone in Rats. Drug Metabolism and Disposition. 28(10). 1153–1161. 5 indexed citations
8.
Fevig, John M., Pieter F. W. Stouten, Robert M. Knabb, et al.. (1999). Preparation of pyrrolidine and isoxazolidine benzamidines as potent inhibitors of coagulation factor Xa. Bioorganic & Medicinal Chemistry Letters. 9(8). 1195–1200. 11 indexed citations
9.
Quan, Mimi L., Christopher D. Ellis, Ann Y. Liauw, et al.. (1999). Design and Synthesis of Isoxazoline Derivatives as Factor Xa Inhibitors. 2. Journal of Medicinal Chemistry. 42(15). 2760–2773. 67 indexed citations
10.
Fevig, John M., Joseph Cacciola, Richard Alexander, et al.. (1998). Preparation of meta-amidino-N,N-disubstituted anilines as potent inhibitors of coagulation factor Xa. Bioorganic & Medicinal Chemistry Letters. 8(22). 3143–3148. 5 indexed citations
11.
Wong, Pancras C., David D. Christ, Nancy Wong, & Gilbert N. Lam. (1996). Nonpeptide Angiotensin II Receptor Antagonist: Pharmacokinetics and Pharmacodynamics in Rats of EXP3174, an Active Metabolite of Losartan. Pharmacology. 52(1). 25–29. 10 indexed citations
12.
Wong, Y. Nancy, et al.. (1996). Pharmacokinetics and metabolism of EXP921, a novel cognitive enhancer, in rats.. Drug Metabolism and Disposition. 24(2). 172–179. 3 indexed citations
13.
Lam, Gilbert N., Susan Erickson‐Viitanen, Lee T. Bacheler, et al.. (1995). A bis-[N-3-(1-hydroxy-1-methyl-ethyl)-benzyl)-cyclic urea as a HIV protease inhibitor. Bioorganic & Medicinal Chemistry Letters. 5(24). 3027–3032. 5 indexed citations
14.
Lam, Gilbert N., et al.. (1994). Determination of linopirdine and its N-oxide metabolites in rat plasma by liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis. 12(8). 1055–1061. 8 indexed citations
15.
Christ, David D., et al.. (1994). The pharmacokinetics and pharmacodynamics of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) in the dog.. Journal of Pharmacology and Experimental Therapeutics. 268(3). 1199–1205. 44 indexed citations
16.
O’Neil, James P., et al.. (1994). Induction of cytochromes P-450 2B and 3A in mice following the dietary administration of the novel cognitive enhancer linopirdine.. Drug Metabolism and Disposition. 22(1). 65–73. 4 indexed citations
17.
Kapil, Ram P., et al.. (1992). Nanogram level quantitation of oxycodone in human plasma by capillary gas chromatography using nitrogen—phosphorus selective detection. Journal of Chromatography B Biomedical Sciences and Applications. 577(2). 283–287. 9 indexed citations
18.
Hussain, Munir, Bruce J. Aungst, Gilbert N. Lam, & Eli Shefter. (1987). Phenylpropanolamine pharmacokinetics in dogs after intravenous, oral, and oral controlled‐release doses. Biopharmaceutics & Drug Disposition. 8(5). 497–505. 16 indexed citations
19.
Chiou, Win L., Gilbert N. Lam, Mei‐Ling Chen, & Myung G. Lee. (1981). Instantaneous input Hypothesis in Pharmacokinetic Studies. Journal of Pharmaceutical Sciences. 70(9). 1037–1039. 12 indexed citations
20.
Lam, Gilbert N. & Win L. Chiou. (1979). Integrated equation to evaluate accumulation profiles of drugs eliminated by Michaelis-Menten kinetics. Journal of Pharmacokinetics and Biopharmaceutics. 7(2). 227–232. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen A. Bai Breakdown of academic impact, for papers by Jörg Pohl Breakdown of academic impact, for papers by Poe‐Hirr Hsyu Breakdown of academic impact, for papers by Hyung‐Doo Park Breakdown of academic impact, for papers by M. Thévenin Breakdown of academic impact, for papers by Peter R. Gwilt Breakdown of academic impact, for papers by Tawfeeg A. Najjar Breakdown of academic impact, for papers by Klaus Kutz Breakdown of academic impact, for papers by E Albengres Breakdown of academic impact, for papers by Pankaj Wadhwa
Rankless by CCL
2026